Lunxu Liu - Concepedia

Author

Lunxu Liu

Sichuan University ORCID

Also Known As

L Liu, LUNXU LIU, Liu Lunxu, Liu, Lunxu, Liwei Zhang, Lun-Xu Liu, Lun-xu LIU, Lun-xu Liu, LunXu LIU, Lunxu LIU

510

Publications

9.8K

Citations

H-Index

102

Concepts

All Affiliations

Sichuan University West China Hospital of Sichuan University Sun Yat-sen University State Key Laboratory of Biotherapy The First Affiliated Hospital, Sun Yat-sen University

About

Lunxu Liu is an author at Sichuan University specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	46	3.1K
2	Health Sciences	9	9	338
3	Engineering	3	3	102
4	Natural Sciences	2	2	84
5	Public Health	1	1	353

Lunxu Liu

128

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung Cancer Wenhua Liang, Li Zhang, Gening Jiang, Journal of Clinical Oncology	2015	690
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study Wen‐Zhao Zhong, Qun Wang, Weimin Mao, The Lancet Oncology MedicinePathologyGefitinib Versus VinorelbineEgfr-mutant NsclcAdjuvant Treatment	2017	520
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry Wenhua Liang, Jiaxi He, Yaxing Shen, Journal of Clinical Oncology Surgical OncologyEpidemiology Of CancerThreshold Eln CountPathologyCancer Registration	2017	353
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial Wen‐Zhao Zhong, Qun Wang, Weimin Mao, Journal of Clinical Oncology	2020	261
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer Yong Peng, Yuntao Dai, Charles L. Hitchcock, Proceedings of the National Academy of Sciences	2013	156
The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer Fuqiang Dai, Lunxu Liu, Guowei Che, BMC Cancer	2010	149
Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer Shuangyan Tan, Dan Sun, Wenchen Pu, Molecular Cancer	2018	147
Interleukin-17 and Prostaglandin E2 Are Involved in Formation of an M2 Macrophage-Dominant Microenvironment in Lung Cancer Lunxu Liu, Dongxia Ge, Lin Ma, Journal of Thoracic Oncology M2 Macrophage-dominant MicroenvironmentCytokineCancer ImmunosurveillanceInflammatory Lung DiseaseLung Inflammation	2012	129
A new concept of endoscopic lung cancer resection: Single-direction thoracoscopic lobectomy Lunxu Liu, Guowei Che, Qiang Pu, Surgical Oncology Surgical OncologySingle-direction Thoracoscopic LobectomyNew ConceptBronchial NeoplasmThoracic Surgery	2009	123
IL-6 and TNF-α promote metastasis of lung cancer by inducing epithelial-mesenchymal transition Guan-Sheng Shang, Lunxu Liu, Yiwei Qin Oncology Letters Healthy SubjectsLung InflammationImmunologyPathologyCancer Biology	2017	121

Page 1